Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?
about
Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.Immunomodulation in hepatocellular cancer.Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection
P2860
Q39006162-94F67803-4CCE-48DC-8534-0485C9E560F6Q40107522-681989D9-6FFF-4F06-9E5D-014421F14912Q40522226-8108040D-6A72-4CE0-A42A-79F7D1B549DCQ47554076-D7FC5289-BCAC-49FB-975D-A01D3EB7BDDBQ52346985-CC208263-E9CD-461A-9D8A-E26E077F024DQ52657977-FCE1804F-A0E1-4CAC-BC6F-E66187F33AA0Q57067833-0EA50B8C-0380-4A3B-9532-656FFF3CAF79
P2860
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Should surveillance for liver ...... -related cirrhosis regression?
@en
type
label
Should surveillance for liver ...... -related cirrhosis regression?
@en
prefLabel
Should surveillance for liver ...... -related cirrhosis regression?
@en
P2860
P356
P1433
P1476
Should surveillance for liver ...... -related cirrhosis regression?
@en
P2093
Massimo Colombo
P2860
P304
P356
10.1111/LIV.13106
P577
2016-03-03T00:00:00Z